Zeposia Tablets Approved in Scotland to Treat Active RRMS

Zeposia Tablets Approved in Scotland to Treat Active RRMS

285712

Zeposia Tablets Approved in Scotland to Treat Active RRMS

The Scottish Medicines Consortium (SMC) has approved Zeposia (ozanimod) for the treatment of active relapsing-remitting multiple sclerosis (RRMS). Zeposia is sold as a tablet, to be taken by mouth once daily. The SMC has recommended that Zeposia be prescribed for people with RRMS who experience relapses or have evidence of disease activity on brain imaging. It’s also recommended for those who prefer or find it easier to take medications as a tablet. “This is excellent news,” David…

You must be logged in to read/download the full post.